Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.

Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe updates appear to be cosmetic UI refinements to the study record page, with core sections such as Eligibility Criteria, Primary/Secondary Outcomes, and Enrollment unchanged. Overall study details remain the same, and no new or removed information is visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision: v3.4.2 appears on the page, replacing the prior v3.4.1 operational funding notice as part of routine site maintenance. This is a routine site maintenance update and does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check23 days agoChange DetectedA government funding notice about site status was added and the revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check30 days agoChange DetectedAdded 'Show glossary' option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous wording.SummaryDifference0.2%

- Check44 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check58 days agoChange DetectedThe Study Details page appears unchanged. No edits to trial design, eligibility criteria, outcomes, or listed locations were detected.SummaryDifference0.1%

Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.